Turn Therapeutics (TTRX) EPS (Weighted Average and Diluted) (2024 - 2026)
Turn Therapeutics (TTRX) recorded quarterly EPS (Weighted Average and Diluted) of -$0.03 in Q1 2026, down 400.0% quarter-over-quarter from $0.01 in Q4 2025, and down 200.0% on a YoY basis from $0.03 in Q1 2025.
Turn Therapeutics (TTRX) EPS (Weighted Average and Diluted) (2024 - 2026) Analysis & Trends
Turn Therapeutics' EPS (Weighted Average and Diluted) history runs 3 years deep, the most recent figure standing at -$0.03 for Q1 2026.
- In Q1 2026, EPS (Weighted Average and Diluted) fell 200.0% year-over-year to -$0.03; the TTM figure through Mar 2026 stood at -$0.1 (changed N/A YoY), while the FY2025 annual figure was -$0.12, down 71.43% from the prior year.
- EPS (Weighted Average and Diluted) was -$0.03 for Q1 2026 at Turn Therapeutics, down from $0.01 in the prior quarter.
- In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $0.01 in Q4 2025 to a low of -$0.07 in Q3 2025.
- Historically, EPS (Weighted Average and Diluted) has averaged -$0.02 across 3 years, with a median of -$0.02 in 2024.
- The sharpest annual moves came in 2025 and 2026: EPS (Weighted Average and Diluted) soared 150.0% in 2025, then sank 200.0% in 2026.
- A 3-year view of EPS (Weighted Average and Diluted) shows it stood at -$0.02 in 2024, then jumped by 150.0% to $0.01 in 2025, then tumbled by 400.0% to -$0.03 in 2026.
- The last three EPS (Weighted Average and Diluted) figures came in at -$0.03 (Q1 2026), $0.01 (Q4 2025), and -$0.07 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 0.68 |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.06 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 3,086.42 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 0.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 0.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 4.02 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -0.61 |
| 10 | Turn Therapeutics | 175.38 Mn | 175.38 Mn | - | -0.03 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.03 |
| Dec 31, 2025 | 0.01 |
| Sep 30, 2025 | -0.07 |
| Mar 31, 2025 | -0.01 |
| Dec 31, 2024 | -0.02 |
| Sep 30, 2024 | -0.03 |